Anticoagulation, Transfusion, and Bleeding Case Lab

Anticoagulation, Transfusion, and Bleeding Case Lab

Shift Report

You are caring for four patients with hematology and medication safety concerns. Room 710 takes warfarin for atrial fibrillation and was admitted for pneumonia. Room 711 started a heparin infusion for pulmonary embolism. Room 712 is postoperative day one after hip repair and has a hemoglobin drop from 10.2 to 7.8 g/dL. Room 713 is receiving packed red blood cells for symptomatic anemia. At 0940, Room 713 reports chills and low back pain 15 minutes after the transfusion begins. At the same time, Room 711 has new gum bleeding and a large ecchymosis at the IV site.

CMSRN questions test whether the nurse recognizes bleeding or transfusion reaction patterns before completing routine tasks. Anticoagulants prevent clot extension and embolic events, but they can create serious harm if bleeding is missed. Transfusions can be life-saving, but fever, chills, flank or back pain, dyspnea, hypotension, urticaria, or anxiety during a transfusion require immediate action.

Rapid Safety Table

Case 1: Transfusion Reaction

For Room 713, the priority is to stop the transfusion immediately. Maintain venous access with normal saline using new tubing according to policy, assess vital signs and symptoms, verify patient and blood product identification, notify the provider and blood bank, and follow facility procedures for returning blood product and tubing if required. Do not slow the transfusion to see if symptoms improve. Do not discard the blood bag. Documentation should include start time, amount infused, symptoms, vital signs, actions taken, notifications, and patient response.

The nurse also monitors for airway or circulatory compromise. If the patient develops hypotension, wheezing, chest pain, dyspnea, or altered mental status, activate emergency response per policy. Reassessment continues after the transfusion is stopped because reactions can progress.

Case 2: Heparin And Bleeding

Room 711 has gum bleeding and extensive bruising while receiving heparin. The nurse assesses vital signs, infusion rate, IV site, skin, urine, stool, mental status, pain, and recent labs such as aPTT or anti-Xa depending on protocol, platelet count, hemoglobin, and hematocrit. Notify the provider or follow the heparin protocol for abnormal results. The nurse should not independently discontinue all anticoagulation unless the protocol or emergency situation directs it, but must act quickly when bleeding is suspected.

Heparin-induced thrombocytopenia is a separate concern when platelets fall significantly or new thrombosis appears after heparin exposure. CMSRN items may ask which finding to report: a platelet drop, new limb pain or swelling, chest pain, neurologic change, or unexpected bleeding. Collaboration with pharmacy and the provider is essential.

Case 3: Warfarin Education And GI Bleeding

Room 710 reports black, tarry stool and dizziness when standing. The nurse obtains orthostatic or current vital signs as appropriate, assesses stool, abdominal symptoms, skin color, mentation, and fall risk, and notifies the provider with warfarin dose, last INR if available, and hemoglobin trend. Teaching for warfarin includes consistent vitamin K intake, bleeding precautions, medication and herbal interaction checks, INR monitoring, avoiding NSAIDs unless approved, using a soft toothbrush and electric razor, and reporting melena, hematuria, severe headache, vomiting blood, or unusual bruising.

Case 4: Postoperative Bleeding

Room 712 has increasing hip dressing drainage, tachycardia, dizziness, and hemoglobin drop. The nurse marks drainage if policy supports it, reinforces rather than removes a fresh surgical dressing unless ordered, assesses distal pulses and neurovascular status, checks vital signs, evaluates pain and swelling, maintains safety, and notifies the surgical team. A low hemoglobin alone may be less urgent than a patient with active bleeding signs and unstable vital signs.

Documentation And Reassessment

Bleeding and transfusion notes must be exact. Record objective descriptions: stool color, amount of drainage, size and location of bruising, urine color, vital signs, neurologic findings, lab values, medication timing, and patient statements. Reassess after interventions: Did blood pressure improve? Did bleeding stop? Did chills resolve after transfusion cessation? Was the provider notified and what orders were received?

CMSRN Synthesis

The best answer usually protects the patient first and then clarifies cause. Stop a suspected transfusion reaction immediately. Treat anticoagulated patients with new neurologic symptoms, hypotension, melena, hematuria, or expanding hematoma as high priority. Education is important, but not during active instability. Collaboration with laboratory, blood bank, pharmacy, and providers prevents small warnings from becoming major harm.